基本資料
種類: ETF
費用比率%: 0.60
資產淨值: 32.37
成立日期: 11/12/2017
 
分析
市值分佈:
90.48%
大市值
5.20%
中市值
1.27%
小市值
持股比例加總可能不達100%,原因包括ETF持有現金或衍生工具。
 
 
行業分佈 國家/地區分佈
 
投資組合
 (更新時間: 19/09/2026 05:39) 總持有投資項目: 179  
0%
 
100%
     10大 (30.36%)
代號 名稱 佔比% ▼ 持有日期
AOSAO Smith Corp0.0231/08/2026
HPQHP0.0231/08/2026
PRTAProthena Corp0.0231/07/2026
SPRYARS Pharmaceuticals0.0231/07/2026
VNDAVanda Pharmaceuticals0.0231/07/2026
OVIDOvid Therapeutics0.0231/07/2026
VRSNVeriSign0.0231/07/2026
MYGNMyriad Genetics0.0231/08/2026
FSLRFirst Solar0.0231/08/2026
ACHVAchieve Life Sciences0.0231/07/2026
CAPRCapricor Therapeutics0.0231/07/2026
PTCPTC0.0131/08/2026
ZBRAZebra Technologies Corp0.0131/08/2026
SGMTSagimet Biosciences Inc. - Series A0.0131/07/2026
BBOTBridgeBio Oncology Therapeutics Inc0.0131/07/2026
MPLTMapLight Therapeutics Inc.0.0131/08/2026
TRMBTrimble0.0131/08/2026
FRC--0.0131/03/2023
GDDYGoDaddy0.0131/08/2026
  1    2    3    4    5    6    7    8   9  
 

Copyright © 2026 ET Net Limited.
All rights reserved. Use of this site signifies your agreement to the terms of use.
DISCLAIMER: ET Net Limited and Third Party Information Providers endeavour to ensure the accuracy and reliability of the information provided, but do not guarantee its accuracy and reliability and accept no liability (whether in tort or contract or otherwise) for any loss or damage arising from any inaccuracies or omissions.